Concepedia

Author

Mauricio Catalá

Center of Molecular Immunology (Cuba)

Also Known As

Fernando Marín Díez, M Catala, M. Catala, M. Catalá, Mauricio Catala, Mauricio Catalá

30

Publications

957

Citations

9

H-Index

20

Concepts

All Affiliations

Center of Molecular Immunology (Cuba)Hermanos Ameijeiras HospitalHospital Oncológico Docente "Conrado Benítez García"University of HolguínCuban Neuroscience Center
MC

About

Mauricio Catalá is an author at Center of Molecular Immunology (Cuba) specializing in immunology, medicine, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

401

2

Immunology

5

5

401

3

Autoimmunity

2

2

113

4

Pathology

1

1

25

5

Autoimmune Disease

1

1

25

Mauricio Catalá

×

9

Publications

913

Citations

9

H-Index

YearCitations

A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients

Pedro C. Rodríguez, Xitllaly Popa, Odeth Martínez,

Clinical Cancer Research

2016

163

Treatment of high-grade glioma patients with the humanized anti-epidermal growth factor receptor (EGFR) antibody h-R3: Report from a phase I/II trial

Tania Crombet, Javier Figueredo, Mauricio Catalá,

Cancer Biology & Therapy

2006

161

A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial

Gabriela Gonzalez, Tania Crombet, Mauricio Catalá,

Annals of Oncology

1998

154

Epidermal growth factor-based cancer vaccine for non-small-cell lung cancer therapy

Gabriela Gonzalez, Tania Crombet, F. Torres,

Annals of Oncology

2003

116

Pharmacological Evaluation of Humanized Anti-Epidermal Growth Factor Receptor, Monoclonal Antibody h-R3, in Patients With Advanced Epithelial-Derived Cancer

Tania Crombet, Leonel Torres, Elia Neninger,

Journal of Immunotherapy

2003

110

Immune responses in breast cancer patients immunized with an anti-idiotype antibody mimicking NeuGc-containing gangliosides

Alain Díaz, Mauro Alfonso, Ruby Alonso,

Clinical Immunology

2003

88

Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial

Maria Teresa Solomón, Julio César Selva, Javier Figueredo,

BMC Cancer

2013

78

Phase I Clinical Evaluation of a Neutralizing Monoclonal Antibody against Epidermal Growth Factor Receptor

Tania Crombet, Olga Torres, Elia Neninger,

Cancer Biotherapy and Radiopharmaceuticals

2001

25

Associations among cytokines, EGF and lymphocyte subpopulations in patients diagnosed with advanced lung cancer

Gisela María Suárez, Ana Laura Añé-Kourí, Amnely González,

Cancer Immunology Immunotherapy

2021

18

Page 1